BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8533277)

  • 21. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological responses to Babesia bovis vaccination in cattle previously infected with Babesia bigemina.
    Combrink MP; Troskie PC; Du Plessis F; Latif AA
    Vet Parasitol; 2010 May; 170(1-2):30-6. PubMed ID: 20207488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on failure of T strain live Babesia bovis vaccine.
    Bock RE; de Vos AJ; Lew A; Kingston TG; Fraser IR
    Aust Vet J; 1995 Aug; 72(8):296-300. PubMed ID: 8579560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen.
    Montenegro-James S; Ristic M; Toro Benitez M; Leon E; Lopez R
    Vet Parasitol; 1985 Dec; 18(4):321-37. PubMed ID: 4090242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
    Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and humoral immune responses induced in cattle by vaccination with Babesia divergens culture-derived exoantigens correlate with protection.
    Valentin A; Precigout E; L'Hostis M; Carcy B; Gorenflot A; Schrevel J
    Infect Immun; 1993 Feb; 61(2):734-41. PubMed ID: 8423099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking Babesia bovis vaccine reactions of dairy cattle in milk.
    Combrink MP; Carr G; Mans BJ; Marais F
    Onderstepoort J Vet Res; 2012 Dec; 79(1):E1-4. PubMed ID: 23327323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culture-derived Babesia orientalis exoantigens used as a vaccine against buffalo babesiosis.
    Zhao JL; Liu ZL; Yao BA; Ma LH
    Parasitol Res; 2002 May; 88(13 Suppl 1):S38-40. PubMed ID: 12051606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an immunodominant 40 kDa merozoite antigen common to the Australian T and Dixie vaccine strains of Babesia bovis and the development of diagnostic tests specific for these strains.
    Molloy JB; Waldron SJ; Jorgensen WK
    Vet Parasitol; 1995 Dec; 60(3-4):229-40. PubMed ID: 8747906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity following use of Australian tick fever vaccine: a review of the evidence.
    Bock RE; de Vos AJ
    Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cattle responses to mono-specific or combined inoculations with Babesia bigemina and Babesia bovis vaccine strains.
    Viseras J; Lugaresi CI; Volpogni MM; Guglielmone AA
    Parasite; 1999 Mar; 6(1):67-9. PubMed ID: 10229940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune control of Babesia bovis infection.
    Brown WC; Norimine J; Knowles DP; Goff WL
    Vet Parasitol; 2006 May; 138(1-2):75-87. PubMed ID: 16510249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Babesia bovis and B. bigemina: Persistence of infection in friesian cows following vaccination with live antibabesial vaccines.
    Pipano E; Shkap V; Kriegel Y; Leibovitz B; Savitsky I; Fish L
    Vet J; 2002 Jul; 164(1):64-8. PubMed ID: 12359486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development of a recombinant Babesia vaccine.
    Wright IG; Casu R; Commins MA; Dalrymple BP; Gale KR; Goodger BV; Riddles PW; Waltisbuhl DJ; Abetz I; Berrie DA
    Vet Parasitol; 1992 Sep; 44(1-2):3-13. PubMed ID: 1441189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of breed of cattle on transmission rate and innate resistance to infection with Babesia bovis and B bigemina transmitted by Boophilus microplus.
    Bock RE; Kingston TG; de Vos AJ
    Aust Vet J; 1999 Jul; 77(7):461-4. PubMed ID: 10451733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses of cattle following vaccination with living and non-living Babesia bovis antigens.
    Timms P; Stewart NP; Rodwell BJ; Barry DN
    Vet Parasitol; 1984 Nov; 16(3-4):243-51. PubMed ID: 6542722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.